Results 241 to 250 of about 1,037,015 (297)

A Rationally Engineered Spleen‐Tropic One‐Component Lipid‐mRNA Complex (OncoLRC) for Cancer Vaccines

open access: yesAdvanced Science, EarlyView.
OncoLRC, a one‐component lipid‐mRNA complex, enables efficient spleen‐targeted delivery at an exceptionally low lipid‐to‐mRNA mass ratio (1.5:1), robustly activates immune responses, inhibits tumor growth, and synergizes with checkpoint blockade, presenting a next‐generation platform for mRNA vaccines.
Qimeng Yin   +4 more
wiley   +1 more source

Elevated interleukin-10, -22, -24, and -26 in serum samples of children with infectious mononucleosis. [PDF]

open access: yesJ Med Biochem
Li D   +9 more
europepmc   +1 more source

Hypertrophic heart failure promotes gut dysbiosis and gut leakage in interleukin 10-deficient mice. [PDF]

open access: yesAm J Physiol Heart Circ Physiol
Ranjan P   +8 more
europepmc   +1 more source

Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets. [PDF]

open access: yesDiscov Oncol
Aslam A   +15 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Interleukin-10

Current Opinion in Immunology, 1992
Despite the short history of interleukin-10, accumulated evidence indicates that this interleukin plays a major role in suppressing immune and inflammatory responses. Yet interleukin-10 also maintains cell viability and acts as a cofactor to promote the growth of lymphoid and myeloid cells in vitro. Here we review the present knowledge on the structure
R, de Waal Malefyt   +4 more
  +7 more sources

Home - About - Disclaimer - Privacy